PhaseI/II_SU011248 L-malate-salt_Advanced GIST in young patients

• Research type

  Research Study

• Full title

  A phase I/II study of Sunitinib in young patients with advanced gastrointestinal stromal tumour

• IRAS ID

  113727

• Contact name

  Andrew Pearson

• Contact email

  andrew.pearson@icr.ac.uk

• Sponsor organisation

  Pfizer Inc.

• Eudract number

  2011-002008-33

• Clinicaltrials.gov Identifier

  NCT01396148

• REC name

  London - Central Research Ethics Committee

• REC reference

  13/LO/0408

• Date of REC Opinion

  5 Jun 2013

• REC opinion

  Further Information Favourable Opinion